Skip to main content

Advertisement

Log in

Extraction of PLGA-Microencapsulated Proteins Using a Two-Immiscible Liquid Phases System Containing Surfactants

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The extraction of proteins from PLGA/PLA microspheres by a two-immiscible liquid phases system with the addition of surfactants was investigated.

Methods

First, the extraction without surfactants and the interaction between proteins (IFN-α2b and EGF) and empty microspheres (PLGA or PLA) was studied. Next, proteins stability in presence of different surfactants was evaluated by: (1) bicinchoninic acid protein assay, (2) reversed phase-high performance liquid chromatography, and (3) enzyme-linked immunosorbent assay. Then, proteins were extracted with PBS/dichloromethane including selected surfactants and characterized by the above mentioned techniques, biological activity tests, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry.

Results

Without surfactants, protein recovery was only 27–43% for IFN-α2b and 58–73% for EGF. Protein content in solutions incubated with blank microspheres decreased to 66% for IFN-α2b and 86% for EGF. It was only possible to quantify the EGF and IFN-α2b in the same manner as in PBS alone when the surfactant added was Pluronic F-68 and SDS, respectively. Addition of these surfactants allowed the complete isolation of both biomolecules from the microspheres. The extraction procedure did not affect the encapsulated proteins.

Conclusion

Proteins can be quantitatively extracted, without changes, from PLGA/PLA microspheres using PBS/dichloromethane system that include an appropriate surfactant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

BCA:

bicinchoninic acid

EGF:

epidermal growth factor

ELISA:

enzyme-linked immunosorbent assay

ESI-MS:

electrospray ionization mass spectrometry

IFN:

interferon

mAb:

monoclonal antibody

PLA:

poly (L-lactide)

PLGA:

poly (DL-lactide-co-glycolide)

PVA:

polyvinyl alcohol

RP-HPLC:

reversed-phase high performance liquid chromatography

SDS-PAGE:

sodium dodecylsulfate-polyacrylamide gel electrophoresis

References

  1. Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci. 2010;99(6):2557–75.

    Article  PubMed  CAS  Google Scholar 

  2. Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release. 2010;146(2):241–60.

    Article  PubMed  CAS  Google Scholar 

  3. Bilati U, Allémann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm. 2005;59(3):375–88.

    Article  PubMed  CAS  Google Scholar 

  4. Fu K, Klibanov AM, Langer R. Protein stability in controlled-release systems. Nat Biotechnol. 2000;18(1):24–5.

    Article  PubMed  CAS  Google Scholar 

  5. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90(3):261–80.

    Article  PubMed  CAS  Google Scholar 

  6. Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, Shepard D, Shahzamani A, Jones AJ, Putney SD. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med. 1996;2(7):795–9.

    Article  PubMed  CAS  Google Scholar 

  7. Saez V, Ramon JA, Aldana R, Pérez D, Hardy E. Microencapsulation of recombinant interferon α-2b into poly (D, L-lactide-co-glycolide) microspheres. Biotecnol Apl. 2008;25(1):31–41.

    CAS  Google Scholar 

  8. Kim HK, Park TG. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol Bioeng. 1999;65(6):661–7.

    Article  Google Scholar 

  9. Kim HK, Park TG. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D, L-lactic-co-glycolic acid) microspheres: morphological effect on protein release. J Control Release. 2004;98(1):115–25.

    Article  PubMed  CAS  Google Scholar 

  10. Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. J Microencapsul. 1998;15(6):699–713.

    Article  PubMed  CAS  Google Scholar 

  11. Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm. 2000;50(2):263–70.

    Article  PubMed  CAS  Google Scholar 

  12. Woo BH, Kostanski JW, Gebrekidan S, Dani BA, Thanoo BC, DeLuca PP. Preparation, characterization and in vivo evaluation of 120-day poly(D, L-lactide) leuprolide microspheres. J Control Release. 2001;75(3):307–15.

    Article  PubMed  CAS  Google Scholar 

  13. Deng XM, Li XH, Yuan ML, Xiong CD, Huang ZT, Jia WX, Zhan YH. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped vibrio cholera antigens. J Control Release. 1999;58(2):123–31.

    Article  PubMed  CAS  Google Scholar 

  14. Sánchez A, Villamayor B, Guo Y, McIver J, Alonso MJ. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int J Pharm. 1999;185(2):255–66.

    Article  PubMed  Google Scholar 

  15. Gupta RK, Chang AC, Griffin P, Rivera R, Guo YY, Siber GR. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. Vaccine. 1997;15(6–7):672–8.

    Article  PubMed  CAS  Google Scholar 

  16. Sah H. Protein behavior at the water/methylene chloride interface. J Pharm Sci. 1999;88(12):1320–5.

    Article  PubMed  CAS  Google Scholar 

  17. Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm. 1998;45(3):285–94.

    Article  PubMed  CAS  Google Scholar 

  18. Crotts G, Park TG. Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-co-glycolide) microparticles. J Control Release. 1997;44(2):123–34.

    Article  CAS  Google Scholar 

  19. Calnan DP, Fagbemi A, Berlanga-Acosta J, Marchbank T, Sizer T, Lakhoo K, Edwards A, Playford R. Potency and stability of C truncated human epidermal growth factor. Gut. 2000;47(5):622–7.

    Article  PubMed  CAS  Google Scholar 

  20. Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med. 2003;349(4):350–7.

    Article  PubMed  CAS  Google Scholar 

  21. Santana H, Espino Y, Franco A, Furrazola G, Hardy E. A sandwich-type enzyme-linked immunosorbent assay for the analysis of recombinant human interferon α-2b. Biotech Tech. 1999;13(5):341–6.

    Article  CAS  Google Scholar 

  22. Ferrero J, Ochagavía ME, Aguilera A, López-Saura P. Interferon antiviral activity titration using the “SUMA” device system. Biotecnol Apl. 1994;11(1):34–42.

    Google Scholar 

  23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–5.

    Article  PubMed  CAS  Google Scholar 

  24. Martínez M, Currás T, Pérez E, Acosta A, Rojas I, Almazán M, Moya G, Pérez LC. Control analítico y especificaciones de calidad del factor de crecimiento epidérmico humano recombinante usado Como materia prima activa en formulaciones farmacéuticas. Biotecnol Apl. 1994;11(1):78–82.

    Google Scholar 

  25. Giteau A, Venier-Julienne MC, Aubert-Pouëssel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350(1–2):14–26.

    Article  PubMed  CAS  Google Scholar 

  26. Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D, L-lactide-co-glycolide) microspheres. J Control Release. 2002;79(1–3):137–45.

    Article  PubMed  CAS  Google Scholar 

  27. Freyre FM, Vázquez J, Duarte C, Ferrá E, López I, Arteaga N. Anticuerpos monoclonales que reconocen los factores de crecimiento epidérmico humano y murino. Interferón y Biotecnología. 1989;6(1):32–46.

    CAS  Google Scholar 

  28. Puchades Y, Ojalvo AG, García Y, Chinea G, Gerónimo H, Vispo NS. Identification of peptide mimics of the epitope recognized by CB-EGF1, a monoclonal antibody EGF specific. Biotecnol Apl. 2005;22(3):203–6.

    Google Scholar 

  29. Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. A novel approach to prepare insulin-loaded poly (lactic-Co-glycolic acid) microcapsules and the protein stability study. J Pharm Sci. 2009;98(5):1712–31.

    Article  PubMed  CAS  Google Scholar 

  30. Woo BH, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18(11):1600–6.

    Article  PubMed  CAS  Google Scholar 

  31. Zhou S, Sun J, Sun L, Dai Y, Liu L, Li X, Wang J, Weng J, Jia W, Zhang Z. Preparation and characterization of interferon-loaded magnetic biodegradable microspheres. J Biomed Mater Res B Appl Biomater. 2008;87(1):189–96.

    PubMed  Google Scholar 

  32. Al-Haushey L, Bolzinger MA, Fessi H, Briancon S. RhEGF microsphere formulation and in vitro skin evaluation. J Microencapsul. 2010;27(1):14–24.

    Article  PubMed  Google Scholar 

  33. Bodo G, Maurer-Fogy I. Characterization of different molecular species in affinity purified recombinant human interferon alpha 2. In: Dianzani F, Rossi GB, editors. The interferon system, vol. 24. New York: Raven; 1986. p. 23–7.

    Google Scholar 

  34. Lu HS, Chai JJ, Li M, Huang BR, He CH, Bi RC. Crystal structure of human epidermal growth factor and its dimerization. J Biol Chem. 2001;276(37):34913–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments and Disclosures

We would like to thank MSc. Haydee Gerónimo, Olga Brito and Joaquín González for EGF and IFN-α2b biological activity assays. We are also grateful to MSc. Yanet Terrero for the RP-HPLC analysis of EGF samples. The authors really appreciate the invaluable help of BSc. Yosep Rodríguez, MSc. Jesús Noda and Dr. Vladimir Besada for performing the ESI-MS analyses.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vivian Saez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saez, V., Ramón, J.A., Caballero, L. et al. Extraction of PLGA-Microencapsulated Proteins Using a Two-Immiscible Liquid Phases System Containing Surfactants. Pharm Res 30, 606–615 (2013). https://doi.org/10.1007/s11095-012-0916-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-012-0916-0

KEY WORDS

Navigation